News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Editas Medicine Co-Founders Present Novel Methods For Improving Genome Editing Specificity In Two Nature Biotechnology Papers



4/28/2014 8:57:23 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Editas Medicine, a transformative genome editing company, today announced the publication of new data highlighting novel approaches to improve the specificity of CRISPR/Cas9 genome editing technology. The data are presented in two papers independently co-authored by company co-founders Keith Joung, M.D., Ph.D. and David Liu, Ph.D. in the current online edition of Nature Biotechnology.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES